Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors

Effects of SSRIs on Sexual Function

Rosen, R. C., Lane, R. M., & Menza, M. A. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 654

Fluvoxamine

Benfield, P., & Ward, A. (1986) · Drugs · doi:10.2165/00003495-198632040-00002 · Cited by 496

Psychoactive Drugs and the Risk of Injurious Motor Vehicle Crashes in Elderly Drivers

Ray, W. A., Fought, R. L., & Decker, M. D. (1992) · American Journal of Epidemiology · doi:10.1093/aje/136.7.873 · Cited by 422

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399

Fluoxetine

Benfield, P., Heel, R. C., & Lewis, S. P. (1986) · Drugs · doi:10.2165/00003495-198632060-00002 · Cited by 336

Paroxetine

Dechant, K. L., & Clissold, S. P. (1991) · Drugs · doi:10.2165/00003495-199141020-00007 · Cited by 324

Relative mortality from overdose of antidepressants

Henry, J. A., Alexander, C., & Sener, E. K. (1995) · BMJ · doi:10.1136/bmj.310.6974.221 · Cited by 290

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+ · Cited by 278

Selective serotonin reuptake inhibitors

Montgomery, S. A., Henry, J. A., McDonald, G. J., Dinan, T. G., LADER, M. H., Hindmarch, I., Clare, A. W., & Nutt, D. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400910-00008 · Cited by 254

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

Anderson, I. M., & Tomenson, B. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800407 · Cited by 249

Pharmacological treatment of depression in people with a primary brain tumour

Beevers, Z. C. R., Hussain, S. Y., Boele, F. W., & Rooney, A. G. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006932.pub4 · Cited by 29

Effects of Previous Major Depressive Illness on Cognition in Alzheimer Disease Patients

Cannon-Spoor, H. E., Levy, J. A., Zubenko, G. S., Zubenko, W. N., Cohen, R. M., Mirza, N., Putnam, K. T., & Sunderland, T. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200504000-00007 · Cited by 26

The Impact of Trends in Psychotropic Prescribing on the Method of Suicide in the Elderly

Shah, A. K., & Lodhi, L. M. (2005) · Medicine Science and the Law · doi:10.1258/rsmmsl.45.2.115 · Cited by 26

P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex

Ren, W., Zhao, Y.-F., Li, J., Rubini, P., Yuan, Z., Tang, Y., & Illés, P. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad166 · Cited by 24

Age and adverse drug reactions from psychopharmacological treatment

Greil, W., Häberle, A., Schuhmann, T., Grohmann, R., & Baumann, P. (2013) · Swiss Medical Weekly · doi:10.4414/smw.2013.13772 · Cited by 24

Are Selective Serotonin Reuptake Inhibitors Safe for Drivers? What is the Evidence?

Ravera, S., Ramaekers, J. G., den Berg, L. T. W. D. J., & de Gier, J. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.04.002 · Cited by 23

An Algorithm for the Diagnosis and Management of Chest Pain in Primary Care

Yelland, M. J., Cayley, W. E., & Vach, W. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.01.011 · Cited by 23

Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs

Kling, A., Lange, U. E. W., Mack, H., Bakker, M. H. M., Drescher, K. U., Hornberger, W., Hutchins, C. W., Möller, A., Müller, R., Schmidt, M. U., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.077 · Cited by 23

A Systematic Review of Pharmacologic Treatments for School Refusal Behavior

Londono Tobon, A., Reed, M. O., Taylor, J. H., & Bloch, M. H. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0160 · Cited by 22

Childhood Predictors of Use and Costs of Antidepressant Medication by Age 24 Years: Findings from the Finnish Nationwide 1981 Birth Cohort Study

Gyllenberg, D., Sourander, A., Niemelä, S., Helenius, H. Y. M., Sillanmäki, L. H., Ristkari, T., Piha, J., Kumpulainen, K., Tamminen, T., Moilanen, I. K., et al. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.12.016 · Cited by 23

Treatment strategies for clozapine-induced nocturnal enuresis and urinary incontinence: a systematic review

Tanzer, T. D., Warren, N., McMahon, L., Barras, M. A., Kisely, S. R., Brooks, E., Wong, E., & Siskind, D. J. (2022) · CNS Spectrums · doi:10.1017/s1092852922000050 · Cited by 22

The Increasing Frequency of Mania and Bipolar Disorder

Yutzy, S. H., Woofter, C., Abbott, C., Melhem, I., & Parish, B. S. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3182531f17 · Cited by 22

Thermal behavior study and decomposition kinetics of amisulpride under non-isothermal and isothermal conditions

Salama, N. N., Mohammad, M. A., & Fattah, T. A. (2015) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-015-4419-1 · Cited by 22

Do Antidepressants Reduce the Burden Imposed by Depression on Employers?

Greener, M., & Guest, J. F. (2005) · CNS Drugs · doi:10.2165/00023210-200519030-00006 · Cited by 22

Elektrostimulationsakupunktur bei peripheren neuropathischen Schmerzsyndromen

Irnich, D., Winklmeier, S., Beyer, A., & Peter, K. (2002) · Der Schmerz · doi:10.1007/s00482-001-0128-8 · Cited by 22

A Self-Controlled, Naturalistic Study of Selective Serotonin Reuptake Inhibitors versus Tricyclic Antidepressants

Faravelli, C., Cosci, F., Ciampelli, M., Scarpato, M. A., Spiti, R., & Ricca, V. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000068689 · Cited by 22

PRELIMINARY STUDY OF A SCALE MEASURING DEPRESSION AND SOMATIC SYMPTOMS

Hung, C., Su, Y., Weng, L., & Liu, C.-Y. (2006) · Psychological Reports · doi:10.2466/pr0.99.2.379-389 · Cited by 20

Pharmacological treatment of depression in patients with a primary brain tumour

Rooney, A. G., & Grant, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006932.pub2 · Cited by 20

Personalized medicine in Alzheimer's disease and depression

Souslova, T., Marple, T. C., Spiekerman, A. M., & Mohammad, A. A. (2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2013.06.012 · Cited by 19

Patients with Major Depression Show Intact Memory Performance—Given Optimal Conditions

Hammar, Å., Isaksen, L., Schmid, M. T., Årdal, G., & Strand, M. (2011) · Applied Neuropsychology · doi:10.1080/09084282.2011.595445 · Cited by 18

Repurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach

Kubick, N., Pajares, M., Enache, I., Manda, G., & Mickael, M. (2020) · Molecules · doi:10.3390/molecules25092155 · Cited by 18

Acupuncture/electroacupuncture enhances anti-depressant effect of Seroxat: the Symptom Checklist-90 scores

Huang, Y., Zhang, Z., Chen, J., Lin, W., Wang, S., Wang, C., Li, G., Qu, S., & Xiao, W. L. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.125353 · Cited by 18

Neuropsychological deficits in major depression reflect genetic/familial risk more than clinical history: A monozygotic discordant twin-pair study

Hsu, K. J., Young‐Wolff, K. C., Kendler, K. S., Halberstadt, L. J., & Prescott, C. A. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.10.037 · Cited by 17

Advancing insights on β-cyclodextrin inclusion complexes with SSRIs through lens of X-ray diffraction and DFT calculation

Aree, T. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121113 · Cited by 17

Antidepressant drugs specifically inhibiting noradrenaline reuptake enhance recognition memory in rats.

Feltmann, K., Konradsson‐Geuken, Å., Bundel, D. D., Lindskog, M., & Schilström, B. (2015) · Behavioral Neuroscience · doi:10.1037/bne0000100 · Cited by 17

Development and validation of a method for analysing of duloxetine, venlafaxine and amitriptyline in human bone

Fernández-López, L., Pellegrini, M., Rotolo, M. C., Maldonado, A. L., Romero, M. F., & Mancini, R. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.04.001 · Cited by 15

Antidepressant use and expenditure in the treatment of patients with depression: Evidence from China urban medical claims data

Ding, R., Wang, Y., Ye, X., Zhu, D., Shi, X., & He, P. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.008 · Cited by 15

Possible involvement of brain-derived neurotrophic factor in the antinociceptive effect of antidepressants in neuropathic pain

Tsai, S. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.03.021 · Cited by 15

Osteoporosis and Fracture Risk Associated with Novel Antidepressants: A Systematic Review and Meta-Analysis

Hu, J., Xie, K., Wu, S., & Chen, Y. (2024) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v52i3.1560 · Cited by 14

Effects of the atypical antidepressant trimipramine on neuronal excitability and long-term potentiation in guinea pig hippocampal slices

Langosch, J. M., & Walden, J. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00269-x · Cited by 14

Antipsychotic drug treatment: recent advances

Barnes, T. R. E., & Joyce, E. M. (2001) · Current Opinion in Psychiatry · doi:10.1097/00001504-200101000-00005 · Cited by 14

Fall-Risk-Increasing Drugs and Gait Performance in Community-Dwelling Older Adults: Exploratory Results from the Gait and Brain Study

Osman, A., Speechley, M. R., Ali, S., & Montero‐Odasso, M. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01045-1 · Cited by 13

Neuropsychologie affektiver Störungen

Beblo, T. (2004) · Springer eBooks · doi:10.1007/978-3-662-08959-0_10 · Cited by 13

Evidence for the use of vilazodone in the treatment of major depressive disorder

Reinhold, J. A., Mandos, L. A., Lohoff, F. W., & Rickels, K. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.721776 · Cited by 13

Antidepressant-like effects of paroxetine are produced by lower doses than those which produce nausea

Tuerke, K. J., Leri, F., & Parker, L. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.05.011 · Cited by 13

Factors Associated With Antidepressant Dosing in Asia

Rajaratnam, K., Xiang, Y., Tripathi, A., Chiu, H. F. K., Si, T., Chee, K., Avasthi, A., Grover, S., Chong, M., Kuga, H., et al. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000591 · Cited by 13

Die Akutbehandlung depressiver Episoden

Holsboer‐Trachsler, E., Hättenschwiler, J. A., Beck, J., Brand, S., Hemmeter, U., Keck, M. E., Rennhard, S., Hatzinger, M., Merlo, M., Bondolfi, G., et al. (2016) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2016.02704 · Cited by 13

Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials

Holper, L., & Hengartner, M. P. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02839-y · Cited by 13

Efficacité clinique et obtention d’une rémission complète dans la dépression : intérêt de l’escitalopram

Favré, P. (2011) · L Encéphale · doi:10.1016/j.encep.2011.11.003 · Cited by 13

Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1ª parte: tratamento agudo e de continuação do transtorno depressivo maior

Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., & Möller, H. (2009) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832009000800001 · Cited by 14

Is it safe to use antidepressants after a stroke?

Rampello, L., Battaglia, G., Raffaele, R., Vecchio, I., & Alvano, A. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.5.885 · Cited by 13

Cost-Effectiveness of Duloxetine in Chronic Low Back Pain

Wielage, R. C., Bansal, M., Wilson, K., Klein, R. W., & Happich, M. (2012) · Spine · doi:10.1097/brs.0b013e31828264f9 · Cited by 12

Vortioxetine overdose in a suicidal attempt

Mazza, M. G., Rossetti, A., Botti, R. E., & Clerici, M. (2018) · Medicine · doi:10.1097/md.0000000000010788 · Cited by 12

Research progress of non-monoamine antidepressants

Zhang, H., Wang, B., & Cao, X. (2021) · Stress and Brain · doi:10.26599/sab.2021.9060002 · Cited by 11

Efficacy and safety of escitalopram versus desvenlafaxine in the treatment of major depression: A preliminary 1-year prospective randomized open label comparative trial

Tandon, V., Gupta, B., Zargar, S., & Arora, M. (2016) · Perspectives in Clinical Research · doi:10.4103/2229-3485.173771 · Cited by 11

The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis

Lubrini, G., Lago, M. R., Periañez, J. A., Barranco, A. T., de Dios, C., Fernández-Fournier, M., Díez‐Tejedor, E., & Frank, A. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516661047 · Cited by 11

Treatment with high-dose antidepressants severely exacerbates the pathological outcome of experimental Escherichia coli infections in poultry

Kromann, S., Kudirkienė, E., Li, L., Thøfner, I. C. N., Daldorph, E., Christensen, J. P., Meng, H., & Olsen, R. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185914 · Cited by 11

Pharmacoepidemiology and drug safety

(2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.546 · Cited by 11

Herbal medicinal products or preparations for neuropathic pain and fibromyalgia

Boyd, A., Bleakley, C., Gill, C. I. R., McDonough, S., Hurley, D. A., Bell, P., McVeigh, J. G., & Hannon-Fletcher, M. P. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010528 · Cited by 11

Concomitant Use of Selective Serotonin Reuptake Inhibitors and Oral Anticoagulants and Risk of Major Bleeding: A Systematic Review and Meta-analysis

Rahman, A. A., He, N., Rej, S., Platt, R. W., & Renoux, C. (2022) · Thrombosis and Haemostasis · doi:10.1055/a-1932-8976 · Cited by 10

Depressive disorders and their pharmacotherapy in routine clinical practice

Mosolov, S. N., Parfenov, V. A., Амелин, А. В., Medvedev, V. E., Mendelevich, В. D., Михайлович, У. Г., Sivolap, Y. P., Bogolepova, A. N., Mkhitaryan, E. A., & Petelin, D. S. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-5-54-64 · Cited by 11

L’escitalopram dans le traitement des épisodes dépressifs majeurs de l’adulte

Llorca, P., Brousse, G., & Schwan, R. (2005) · L Encéphale · doi:10.1016/s0013-7006(05)82410-8 · Cited by 10

Antidepressivos e alterações no peso corporal

Peixoto, H. G. E., Vasconcelos, I. A. L., Sampaio, A. C. M., & Ito, M. (2008) · Revista de Nutrição · doi:10.1590/s1415-52732008000300009 · Cited by 9

Die Bedeutung kognitiver Beeinträchtigungen bei depressiven Patienten

Beblo, T. (2016) · Zeitschrift für Neuropsychologie · doi:10.1024/1016-264x/a000174 · Cited by 8

The Herb-Drug Pharmacokinetic Interaction of Fluoxetine and Its Metabolite Norfluoxetine with a Traditional Chinese Medicine in Rats by LC-MS/MS

Yan, L., Wang, S., Zhao, L., Qiu, J., Zhou, L., Wang, W., Xu, X., Wang, D., Qiu, X., & Qin, D. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2471870 · Cited by 8

QSAR Study on Dual 5‐HT1A and 5‐HT1B Antagonists: An Insight into the Structural Requirement for Antidepressant Activity

Dessalew, N. (2008) · Archiv der Pharmazie · doi:10.1002/ardp.200700224 · Cited by 8

Pharmacological Treatment of Insomnia

Schweitzer, P. K., Curry, D. T., Eisenstein, R. D., & Walsh, J. K. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-042-7_23 · Cited by 9

The relationship between residual symptoms of depression and emotional information processing

Strand, M., Sætrevik, B., Lund, A., & Hammar, Å. (2012) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2012.711857 · Cited by 7

Genotyping of patients treated with selective serotonin reuptake inhibitors

Solhaug, V., Haslemo, T., Kringen, M. K., Molden, E., & Dietrichs, E. S. (2022) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.22.0017 · Cited by 7

Prevalence of Selective Serotonin Reuptake Inhibitors in Pilot Fatalities of Civil Aviation Accidents, 1990-2001

Akin, A., & Chaturvedi, A. (2003) · PsycEXTRA Dataset · doi:10.1037/e734372011-001 · Cited by 7

Adaptation of Cognitive Behaviour Therapy for Depression in Pakistan

Naeem, F. (2012) · ePrints Soton (University of Southampton) · Cited by 7

Pharmacogenomic testing for CYP2C19 and CYP2D6 in cyclic vomiting syndrome

Patel, M., Partovi, O., Karrento, K., Garacchi, Z., Balasubramanian, G., & Venkatesan, T. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14705 · Cited by 6

Individualized multidisciplinary therapy for vulvodynia

Penteado, S. R. L., Bonduki, C. E., de Araújo, T. R. E., Alves, S. V., Batista, N. M. T. D. L., Ambrogini, C. C., & Sartori, M. G. F. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15829 · Cited by 6

Older adults recently started on psychotropic medication: where are the symptoms?

Maust, D. T., Chen, S. H., Benson, A., Mavandadi, S., Streim, J. E., DiFilippo, S. D., Snedden, T. M., & Oslin, D. W. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4187 · Cited by 6

DSP‐1053, a novel serotonin reuptake inhibitor with 5‐HT1Apartial agonistic activity, displays fast antidepressant effect with minimal undesirable effects in juvenile rats

KATO, T., Matsumoto, Y., Yamamoto, M., Matsumoto, K., Baba, S., Nakamichi, K., Matsuda, H., Nishimuta, H., & Yabuuchi, K. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.142 · Cited by 7

Maximizing Function and Quality of Life of Patients with Glioblastoma after Surgical Resection: A Review of Current Literature

Smith-Cohn, M., Chen, Z., Peereboom, D. M., & Stevens, G. H. J. (2016) · Journal of Cancer Therapy · doi:10.4236/jct.2016.712085 · Cited by 6

Liver function under interferon/ribavirin therapy of chronic hepatitis C.

Stintzing, S., Schmitt, C., Ocker, M., Ganslmayer, M., Zopf, S., Gahr, S., Hahn, E. G., & Herold, C. J. (2009) · PubMed · Cited by 6

Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP‐432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects

Sramek, J. J., Hardy, L. W., Bieck, P., Zamora, C., Versavel, M., Kharidia, J., Grinnell, T., Chen, Y., Sullivan, M., Ding, H., et al. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12513 · Cited by 5

Brain metastases and treatment: multiplying cognitive toxicities

Nassif, E. F., Arsene-Henry, A., & Kirova, Y. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1582336 · Cited by 5

Chronic Fluoxetine Treatment Reverses Depressive-like Behaviors in Mice via Enhancing Neuroplasticity

Qian, X., Zhang, Y., & Tan, H.-J. (2023) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.1177/0976500x231224528 · Cited by 5

Die somatische Behandlung der unipolaren depressiven Störungen. Teil 1

Holsboer‐Trachsler, E., Hättenschwiler, J., Beck, J., Brand, S., Hemmeter, U., Keck, M. E., Rennhard, S., Hatzinger, M., Merlo, M. C. G., Bondolfi, G., et al. (2010) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2010.07340 · Cited by 5

Evidence-Based Korean Pharmacological Treatment Guideline for Depression, Revised Edition (I) : Initial Choice of Antidepressant Treatment

Park, S., Sung, S.-H., Han, K., Won, E., Lee, H.-Y., Paik, J., Jeon, H. J., Lee, M., Shim, S.-H., Ko, Y., et al. (2013) · 신경정신의학 · doi:10.4306/jknpa.2013.52.4.253 · Cited by 5

Unipolare Depression – Pharmakotherapie und Psychotherapie (ICD-10 F3)

Schmauß, M., Schramm, E., & Berger, T. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50011-3 · Cited by 5

Drug utilization patterns of antidepressants in Federal Neuro-Psychiatric Hospital Lagos, Nigeria

Kehinde, O., Anyika, E. N., & Abah, I. O. (2017) · Journal of Hospital Administration · doi:10.5430/jha.v6n5p12 · Cited by 5

Preoperative SSRI use increases perioperative transfusion need in patients undergoing surgical procedures on the hip joint

Hoveidaei, A. H., Raeini, A. G., Fallahi, M. S., Habibzadeh, A., Khonji, M. S., Nwankwo, B. O., Palikhey, S., & Conway, J. D. (2024) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-024-04069-4 · Cited by 4

Antidepressant therapy with milnacipran and venlafaxine

Briley, M. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s11776 · Cited by 4

Pharmacologic Treatments of Insomnia

Chu, M. K. (2006) · Journal of Korean Sleep Research Society · doi:10.13078/jksrs.06008 · Cited by 4

Herbal medicinal products or preparations for neuropathic pain

Boyd, A., Bleakley, C., Hurley, D. A., Gill, C. I. R., Hannon-Fletcher, M. P. A., Bell, P., & McDonough, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010528.pub3 · Cited by 4

Use and impact of antidepressants in the school setting

Noggle, C. A., & Dean, R. S. (2009) · Psychology in the Schools · doi:10.1002/pits.20426 · Cited by 4

Treatment of depression with selective serotonin inhibitors: the role of fluvoxamine

Pallanti, S., & Sandner, C. (2007) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500701419685 · Cited by 4

Correlation Between Stress, Anxiety and Depression of Patients with Rheumatoid Arthritis During COVID-19 Pandemic and Their Non-compliance to Treatment: A Cross-sectional Study

Tasorian, B., Tabatabaei, M., & Shayganfard, M. (2022) · Shiraz E-Medical Journal · doi:10.5812/semj-117966 · Cited by 3

Exercise for the treatment of depression

Baron, D. A., Lasarow, S., & Baron, S. H. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316157565.004 · Cited by 3

Neuropsychologie affektiver Störungen

Beblo, T. (2010) · Springer eBooks · doi:10.1007/978-3-540-72340-0_11 · Cited by 3

Effects of Initiating Different Antidepressant Subclasses on Motor Vehicle Crash Risk Among Older Adults With Depression

Khan, M. A., Joyce, N. R., Pfeiffer, M. R., Riester, M. R., Ott, B. R., Oganisian, A., Curry, A. E., Margolis, S. A., & Zullo, A. R. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19527 · Cited by 2

Formulation development, optimization, and evaluation of taste–masked medicated chewing gum of sertraline

Kaushik, P., Mittal, V., & Kaushik, D. K. (2025) · Therapeutic Delivery · doi:10.1080/20415990.2025.2508685 · Cited by 2

Effets secondaires des antidépresseurs

Lôo, H., & Olié, J. (2004) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/j.emcps.2004.05.003 · Cited by 2

Neuropsychological Impairment of Patients with Depression

Beblo, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_9 · Cited by 2

Serotonin Reuptake Inhibitors and Other Atypical Antidepressants

Palatnick, W. (2007) · Elsevier eBooks · doi:10.1016/b978-0-7216-0693-4.50033-5 · Cited by 2

Review on Antidepressant Medication

Kaulage, S. R., Aldar, K. T., Jadhav, R. P., Jadhav, P. D., & Yadhav, V. D. (2019) · International Journal of Scientific Research in Science and Technology · doi:10.32628/ijsrst1962118 · Cited by 2

Serotonin Receptors and Antidepressants: Neuroimaging Findings from Preclinical and Clinical Research

Handschuh, P. A., Konadu, M. E., Spurny‐Dworak, B., Silberbauer, L., Murgaš, M., & Lanzenberger, R. R. (2022) · Neuromethods · doi:10.1007/978-1-0716-2083-0_18 · Cited by 2

Safety differentiation: emerging competitive edge in drug development

Uteng, M., Urbán, L., Brees, D., Muller, P. Y., Kullak-Ublick, G. A., Bouchard, P. R., Tougas, G. H., & Chibout, S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.009 · Cited by 2

Prolactinémie et médicaments psychotropes actuels

Lancelin, F., Poirier-Bègue, E., Mestre, B., Carre, C., Baldach, A., & Piketty, M. (2001) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/s0923-2532(01)80021-1 · Cited by 2

Peripartum Depression and Its Underlying Mechanisms: Transmitters, Information, Endocrinology, and Beyond

Ein‐Dor, T. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_29 · Cited by 1

Design and application of mixed cation exchange modified zirconium dioxide composite-based magnetic polymers for determination of nine tricyclic psychotropic drugs in human plasma samples

Ye, J., Gao, G., Pan, S., & Chen, X. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.117698 · Cited by 1

Exploring Genetic and Receptor-Based Dopaminergic Strategies for Antidepressant Drug Development

Pannu, A. S., & Goyal, R. K. (2025) · Current Gene Therapy · doi:10.2174/0115665232334693250110175517 · Cited by 1

Case Report: Severe SIADH and QTc prolongation induced by escitalopram-quetiapine interaction in a CYP2C19 intermediate metabolizer at therapeutic doses

蒋宗辰, Qu, X., Yan, Z., Fang, J., Lan, J., Zhao, X., & Qi, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1776959 · Cited by 1

Depression in Older Patients

Rabheru, K. (2006) · Elsevier eBooks · doi:10.1016/b978-012369391-4/50060-6 · Cited by 1

Antidepressant-Antianxiety Agents

Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_4 · Cited by 1

Tricyclic antidepressants for autism spectrum disorder

Hurwitz, R., Blackmore, R., Hazell, P., Williams, K. J., Woolfenden, S. R., & Wheeler, D. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008372 · Cited by 1

Long term studies of depression: what is relevant for the physician?

Fakra, É., Fonséca, D. D., Livolsi, S., Destoppeleire, C., & Lançon, C. (2006) · The European Journal of Psychiatry · doi:10.4321/s0213-61632006000400005 · Cited by 1

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability

Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940

Review: selective serotonin reuptake inhibitors are as effective as tricyclic antidepressants overall but may be less effective in some patient subgroups

Nolen, W. A. (2000) · Evidence-Based Mental Health · doi:10.1136/ebmh.3.4.106

A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta‐analysis

Wilson, K., & Mottram, P. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1156 · Cited by 107

Efficacy, safety, and indications for tricyclic and newer antidepressants

Kasper, S. F., Lépine, J., Mendlewicz, J., Montgomery, S. A., & Rush, A. J. (1994) · Depression · doi:10.1002/depr.3050020304 · Cited by 18

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+ · Cited by 278